Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 03 Jun 2024
surprisingly provides a potential boost to overall survival, according to researchers.
Read Full NewsThe history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.
US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.
Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.
Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.
A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.
Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.
1.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
2.
The lack of psychiatrists may be addressed by community workers.
3.
Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.
4.
World's premier cancer institute faces crippling cuts and chaos
5.
Living in a more pedestrian-friendly area may reduce the risk of cancer and obesity-related diseases.
1.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
2.
From Bruises to Blood Clots: Everything You Need to Know about Hematoma
3.
Emerging Therapies Through Artificial Bone Marrow Niche Engineering
4.
Oncologic Emergencies: Diagnosis and Treatment
5.
Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
3.
Oropharyngeal Cancer in Relation to HPV Status
4.
Navigating the Complexities of Ph Negative ALL - Part VI
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge